The present and future agenda of SIOG
The present and future agenda of SIOG
SIOG 2020: Prostate task force and geriatric oncology during COVID 19
Long-term follow-up of low-intensity chemotherapy with combination therapy for r/r Ph- acute lymphoblastic leukaemia patients
Big data, machine learning and drug discovery in oncology
SABCS 2020: Conference roundup
Researchers trace the origin of blood cancer to early childhood, decades before diagnosis
Risk profiling of relapsed/refractory diffuse large B-cell lymphoma patients by measuring circulating tumour DNA
Circulating tumour cell dynamics as a predictor for treatment response and prognosis in metastatic breast cancer patients
ETNK1 mutations in atypical chronic myeloid leukaemia can be reverted with phosphoethanolamine
Latest data for managing ALK NSCLC patients
FORTE: Impact of imaging FDG-PET/CT minimal residual disease assessment on multiple myeloma patients
Pregnancy outcomes in breast cancer survivors; meta-analysis